Masimo (MASI) Short-term Investments (2010 - 2020)
Masimo's quarterly Short-term Investments came in at $50.0 million in Q3 2020, down 58.33% year-on-year from $120.0 million in Q3 2019, and little changed quarter-over-quarter from $50.0 million in Q2 2020.
Masimo has reported Short-term Investments for 3 years, with the latest figure at $50.0 million in Q3 2020.
- For the quarter ending Q3 2020, Short-term Investments fell 58.33% year-over-year to $50.0 million; the trailing twelve-month figure through Sep 2020 stood at $50.0 million (down 58.33% YoY), and the FY2019 full-year result was $120.0 million, changed N/A from the prior year.
- Short-term Investments for Q3 2020 stood at $50.0 million, roughly flat from $50.0 million in the prior quarter.
- The five-year high for Short-term Investments was $180.0 million in Q1 2019, with the low at $50.0 million in Q1 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Masimo | 9.32 Bn | 9.20 Bn | 250.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 26, 2020 | 50.00 Mn |
| Jun 27, 2020 | 50.00 Mn |
| Mar 28, 2020 | 50.00 Mn |
| Dec 28, 2019 | 120.00 Mn |
| Sep 28, 2019 | 120.00 Mn |
| Jun 29, 2019 | 180.00 Mn |
| Mar 30, 2019 | 180.00 Mn |
| Jan 2, 2010 | 56.99 Mn |